Policy & Medicine April 1, 2021
Thomas Sullivan

In early March 2021, the United States Food and Drug Administration (FDA) unveiled its Data Modernization Action Plan (DMAP), an addition to the agency’s Technology Modernization Action Plan (TMAP).

While the previously published TMAP focuses on technology modernization as a whole and lays the groundwork for the FDA’s strategy for data and data management, the DMAP narrows that focus to “the stewardship, security, quality control, analysis, and real-time use of data to accelerate the path to better therapeutic and diagnostic options for people and animals, better secure the food supply chain, and provide state-of-the-art tools to enhance and promote public health.”

Despite society’s shift to digital technologies (especially over the last year!), FDA says its data systems “are still largely geared to...

Today's Sponsors

Teladoc Health
Premier
TripleTree

Today's Sponsors

SalesSparx
Canton & Company

Today's Sponsor

HLTH

 
Topics: Big Data, FDA, Govt Agencies, Technology
The FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar
To Improve Competition In Generic Drug Markets, The FDA Should Discount User Fees For Small Players
FDA-cleared AI devices lack critical information on performance, equity
FDA greenlights Medtronic's AI tool that finds polyps during colonoscopies
Digital Twins 101